The CEO Behind One of Cathie Wood's Favorite Stocks

The video discusses NBT's focus on integrating genetics into mainstream healthcare to improve outcomes globally. It highlights the company's decade-long investment in genetic information and its transformative potential. The discussion includes significant investments from SoftBank and the expansion of infrastructure to scale operations. The impact of COVID-19 on the business is addressed, noting a temporary revenue drop but a positive long-term outlook for recovery and growth.

How did the COVID crisis affect NBT's business operations?

What is the expected trajectory of NBT's business post-COVID?